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Field-collected ticks were used to infect goats with either Ap-ha, a strain associated with human disease, or
a variant strain, Ap-Variant 1, of Anaplasma phagocytophilum. Goats were shown to be competent as a reservoir
for Ap-Variant 1, and challenge and immunosuppression studies were used to further examine infection in the
goat model.
Ap-Variant 1 represents a distinct strain of Anaplasma
phagocytophilum that has not been associated with human dis-
ease. White-tailed deer (Odocoileus virginianus) appear to
serve as a natural reservoir for Ap-Variant 1, and to date they
are the only vertebrate species known to harbor this strain (1,
6, 7). However, deer are difficult to use in a laboratory setting
and require specialized large animal facilities. Therefore, the
potential for the domestic goat to serve as a smaller ruminant
animal model was examined. The competency of goats as a
natural reservoir for Ap-Variant 1 was also evaluated by tick-
feeding and transmission studies.
Questing adult and nymphal ticks were collected by flag-
ging from South Kingstown, Rhode Island, and allowed to
feed on three pathogen-free goats. Two of the goats (A and
B) became infected with A. phagocytophilum strains whose
16S rRNA sequences matched that of the human pathogenic
strain Ap-ha. The third goat (goat C) became infected with
the Ap-Variant 1 strain, as demonstrated by PCR amplifi-
cation from blood and DNA sequencing, as previously de-
scribed (8). EDTA-treated blood (3.5 ml) collected from
goat C at 3 weeks postinfection was used to infect goat D
with Ap-Variant 1. This showed that the DNA detected by
PCR in the blood of goat C represented viable organisms.
Larval and nymphal ticks were allowed to feed on goat C,
allowed to molt, and fed on goat E, which became infected
with Ap-Variant 1, thereby demonstrating the reservoir
competency of goats.
Blood smears were prepared from goat D on day 14
postinjection, stained for visualization of cellular morphol-
ogy, and fluorescein labeled using anti-A. phagocytophilum
antibodies (Fig. 1). The fluorescein-labeled image (Fig. 1B)
demonstrates that Ap-Variant 1 was detected only in seg-
mented neutrophils. Blood samples from goats C, D, and E
were collected sequentially and assessed for infection and
serological titers. End-point titers in the sera were deter-
mined by an immunofluorescence assay using a fluorescein
isothiocyanate-labeled rabbit anti-goat conjugate (Rockland
Immunochemicals, Gilbertsville, PA). Table 1 summarizes
the source of infection and PCR, DNA sequencing, and
immunofluorescence assay results for each of the five goats.
Only goat A showed signs of clinical illness, including fever,
lethargy, lameness, loss of appetite, and nasal discharge.
Goat E was further tested every 2 to 3 days for 3 months by
use of complete blood counts with differential and serum
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FIG. 1. Blood smear of EDTA-treated goat blood infected with
Ap-Variant 1. The cells in panel A are stained to allow visualization of
cellular morphology. Panel B shows the same cells labeled with fluo-
rescein, using anti-A. phagocytophilum antibodies, to identify Ap-Vari-
ant 1 bacteria.
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chemistry profiles. Goat E had a slightly elevated tempera-
ture (103.5°F) on day 7 postinfestation only and showed
mild and transient neutropenia and lymphopenia on days 10
and 7 postinfestation, respectively. Otherwise, goat E showed
normal serum profiles and blood cell counts during the infection
and through 3 months postinfestation.
Although each of the three goats infected with Ap-Variant 1
were PCR positive for various lengths of time, the infections
appeared to be cleared because each goat was PCR negative
past day 24. To assess the clearance of Ap-Variant 1 in goats,
goat D was treated on day 110 postinfection and for five con-
secutive days with an intramuscular dose (4 mg/kg body
weight) of dexamethasone as a strong immunosuppression reg-
imen (3, 4). Goat D remained PCR negative through day 32
posttreatment, and the serum titer remained stable, at 128.
These results suggest that goat D had cleared the Ap-Variant
1 infection.
Goat C was treated with a regimen of the antibiotic
oxytetracycline (10) at 3 months postinfection and, 25 days
after treatment, infested with 50 nymphal ticks that were
infected with Ap-ha. This goat became PCR positive on day
11 and remained positive through day 25, and the infectious
agent was confirmed to be Ap-ha by DNA sequencing.
Whereas the titer of goat C was 1/32 prior to the challenge,
by day 21 postinfestation the titer had risen to 1/2,048.
These results demonstrate that the immune response in-
duced by infection with Ap-Variant 1 did not provide pro-
tection from a subsequent infection with Ap-ha. This is in
agreement with prior studies where sheep and mice were not
protected when challenged with heterologous strains of A.
phagocytophilum (5, 11).
Our ability to characterize the biological and molecular fea-
tures of Ap-Variant 1 has been limited by several factors,
primarily the lack of a tissue culture isolate of the agent and
the lack of an animal model for laboratory studies. The current
study addresses the latter of these needs and demonstrates that
the domestic goat can be infected by the Ap-Variant 1 strain
and is competent as a reservoir for maintenance of the agent in
a natural vertebrate host-tick vector cycle. Blood from infected
goats also provides an excellent resource for ongoing attempts
to make a tissue culture isolate of the variant strain. The
availability of sera from Ap-Variant 1-infected goats also pro-
vides a useful reagent that can be applied to characterizing the
Ap-Variant 1 strain by use of Western blots, immunoprecipi-
tation, or other methods for examining the antigenic compo-
sition of the agent.
Ap-Variant 1 has now been shown to infect goats and
white-tailed deer but is not infectious in mice, hamsters, and
gerbils (7; data not shown). These data suggest that Ap-
Variant 1 is restricted to ruminant species and represents a
lineage distinct from Ap-ha, which infects humans and nu-
merous other mammals. A similar distinction between ru-
minant and nonruminant lineages in Europe has been sug-
gested (9). However, the pathogenic potentials of ruminant
strains from Europe and North America appear to differ
dramatically. Tick-borne fever in Europe is a well-docu-
mented disease of sheep, cattle, and goats characterized by
an acute febrile illness, with mortality rates as high as 30%
in lamb herds (2, 12–14). In contrast, our experimental
Ap-Variant 1 infections of goats caused few apparent clin-
ical symptoms. This suggests that the North American Ap-
Variant 1 strain has evolved into a less pathogenic form than
the European ruminant strains. While Ap-Variant 1 has low
pathogenic potential based on our experimental infections,
it may be that the agent causes morbidity and mortality in a
domestic or wildlife species that has not yet been examined.
Continued studies are needed to examine the host range of
Ap-Variant 1 to determine if ruminants other than white-
tailed deer and goats are susceptible to infection and
whether restriction of the variant to ruminant species is
absolute.
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